Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 Jun;58(6):1796–1801. doi: 10.1128/iai.58.6.1796-1801.1990

Effect of Friend leukemia virus infection on susceptibility to Candida albicans.

M A Moors 1, S M Jones 1, K K Klyczek 1, T J Rogers 1, H R Buckley 1, K J Blank 1
PMCID: PMC258725  PMID: 2341179

Abstract

Previous studies have demonstrated that Friend leukemia virus (FLV) induces a profound immunosuppression in susceptible mice. The studies described in this report indicate that mice infected with FLV have an increased susceptibility to subsequent infection with the opportunistic pathogen Candida albicans, as measured by increased numbers of C. albicans CFU in the kidneys of FLV-infected mice relative to uninfected controls. Experiments in which the NB-tropic and N-tropic strains of FLV were used suggest that virus replication or the resulting virus burden may be important in the observed increased susceptibility to C. albicans. Since neutrophils are believed to be important in the response of mice to systemic Candida infections, the effect of FLV infection on neutrophil candidacidal activity was investigated. The percentage of neutrophils present in unfractionated Proteose Peptone-elicited peritoneal exudates of mice infected with FLV for 14 days was significantly lower than in uninfected control mice or mice infected with FLV for 6 or 10 days. When neutrophils from FLV-infected and control mice were purified, adjusted to equal concentrations, and tested for in vitro candidacidal activity, neutrophils from mice infected with FLV for 14 days were deficient in their ability to kill C. albicans relative to normal controls and mice infected with FLV for 6 or 10 days. Addition of normal mouse serum increased killing in all groups but did not restore candidacidal activity of neutrophils from mice infected with FLV for 14 days to levels of control neutrophils or neutrophils from mice infected for 6 or 10 days with the virus. These results suggest a defect in neutrophil function, at the later stages of FLV infection, involving in vitro candidacidal activity. In addition, neutrophils from FLV-infected mice may be deficient in in vivo chemotactic activity. These defects in neutrophil function could account, at least in part, for the observed increased susceptibility of FLV-infected mice to C. albicans.

Full text

PDF
1796

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELRAD A. A., STEEVES R. A. ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE. Virology. 1964 Nov;24:513–518. doi: 10.1016/0042-6822(64)90199-0. [DOI] [PubMed] [Google Scholar]
  2. Abramson J. S., Mills E. L. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev Infect Dis. 1988 Mar-Apr;10(2):326–341. doi: 10.1093/clinids/10.2.326. [DOI] [PubMed] [Google Scholar]
  3. Ashman R. B. Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex. Immunogenetics. 1987;25(3):200–203. doi: 10.1007/BF00344035. [DOI] [PubMed] [Google Scholar]
  4. Baccarini M., Blasi E., Puccetti P., Bistoni F. Phagocytic killing of Candida albicans by different murine effector cells. Sabouraudia. 1983 Dec;21(4):271–286. [PubMed] [Google Scholar]
  5. Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun. 1986 Feb;51(2):668–674. doi: 10.1128/iai.51.2.668-674.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blank K. J., Murasko D. M. Induction of interferon in AKR mice by murine leukaemia viruses. Nature. 1980 Jan 31;283(5746):494–495. doi: 10.1038/283494a0. [DOI] [PubMed] [Google Scholar]
  7. Borish L., Rosenbaum R., Albury L., Clark S. Activation of neutrophils by recombinant interleukin 6. Cell Immunol. 1989 Jul;121(2):280–289. doi: 10.1016/0008-8749(89)90026-9. [DOI] [PubMed] [Google Scholar]
  8. Buller R. M., Yetter R. A., Fredrickson T. N., Morse H. C., 3rd Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J Virol. 1987 Feb;61(2):383–387. doi: 10.1128/jvi.61.2.383-387.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Butler R. C., Frier J. M., Chapekar M. S., Graham M. O., Friedman H. Role of antibody response helper factors in immunosuppressive effects of friend leukemia virus. Infect Immun. 1983 Mar;39(3):1260–1264. doi: 10.1128/iai.39.3.1260-1264.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ceglowski W. S., Campbell B. P., Mortensen R. F., Friedman H. Humoral and cellular immune responses in susceptible and resistant strains of mice infected with friend leukemia virus. Proc Soc Exp Biol Med. 1974 Jun;146(2):619–624. doi: 10.3181/00379727-146-38159. [DOI] [PubMed] [Google Scholar]
  11. Ceglowski W. S., Friedman H. Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J Natl Cancer Inst. 1968 May;40(5):983–995. [PubMed] [Google Scholar]
  12. Cenci E., Romani L., Vecchiarelli A., Puccetti P., Bistoni F. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect Immun. 1989 Nov;57(11):3581–3587. doi: 10.1128/iai.57.11.3581-3587.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Copelan E. A., Rinehart J. J., Lewis M., Mathes L., Olsen R., Sagone A. The mechanism of retrovirus suppression of human T cell proliferation in vitro. J Immunol. 1983 Oct;131(4):2017–2020. [PubMed] [Google Scholar]
  14. Cutler J. E. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J Reticuloendothel Soc. 1976 Feb;19(2):121–124. [PubMed] [Google Scholar]
  15. Dent P. B. Immunodepression by oncogenic viruses. Prog Med Virol. 1972;14:1–35. [PubMed] [Google Scholar]
  16. Djeu J. Y., Blanchard D. K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol. 1986 Nov 1;137(9):2980–2984. [PubMed] [Google Scholar]
  17. Djeu J. Y., Parapanissios A., Halkias D., Friedman H. A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods. 1986 Aug 21;92(1):73–77. doi: 10.1016/0022-1759(86)90505-3. [DOI] [PubMed] [Google Scholar]
  18. Friedman H., Ceglowski W. S. Leukemia virus-induced immunosuppression. 8. Rapid depression of in vitro leukocyte migration after infection of mice with Friend leukemia virus. J Immunol. 1971 Dec;107(6):1673–1681. [PubMed] [Google Scholar]
  19. Genovesi E. V., Livnat D., Collins J. J. Immunotherapy of murine leukemia. VII. Prevention of Friend leukemia virus-induced immunosuppression by passive serum therapy. Int J Cancer. 1982 Nov 15;30(5):609–624. doi: 10.1002/ijc.2910300512. [DOI] [PubMed] [Google Scholar]
  20. Giger D. K., Domer J. E., Moser S. A., McQuitty J. T., Jr Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice. Infect Immun. 1978 Sep;21(3):729–737. doi: 10.1128/iai.21.3.729-737.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hartley J. W., Rowe W. P. Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology. 1975 May;65(1):128–134. doi: 10.1016/0042-6822(75)90013-6. [DOI] [PubMed] [Google Scholar]
  22. Hirano S., Friedman H., Ceglowski W. S. Immunosuppression by leukemia viruses. VII. Stimulatory effects of Friend leukemia virus on pre-existing antibody-forming cells to sheep erythrocytes and Escherichia coli in non-immunized mice. J Immunol. 1971 Nov;107(5):1400–1409. [PubMed] [Google Scholar]
  23. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  24. Kumar V., Caruso T., Bennett M. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells. J Exp Med. 1976 Apr 1;143(4):728–740. doi: 10.1084/jem.143.4.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kumar V., Resnick P., Eastcott J. W., Bennett M. Mechanism of genetic resistance to Friend virus leukemia in mice. V. Relevance of Fv-3 gene in the regulation of in vivo immunosuppression. J Natl Cancer Inst. 1978 Oct;61(4):1117–1123. [PubMed] [Google Scholar]
  26. Lee K. L., Buckley H. R., Campbell C. C. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia. 1975 Jul;13(2):148–153. doi: 10.1080/00362177585190271. [DOI] [PubMed] [Google Scholar]
  27. Lehrer R. I. Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest. 1972 Oct;51(10):2566–2572. doi: 10.1172/JCI107073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lehrer R. I. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils. Infect Immun. 1970 Jul;2(1):42–47. doi: 10.1128/iai.2.1.42-47.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Levy M. H., Wheelock E. F. Impaired macrophage function in Friend virus leukemia: restoration by statolon. J Immunol. 1975 Mar;114(3):962–965. [PubMed] [Google Scholar]
  30. Lopez-Cepero M., Specter S., Matteucci D., Friedman H., Bendinelli M. Altered interleukin production during Friend leukemia virus infection. Proc Soc Exp Biol Med. 1988 Jul;188(3):353–363. doi: 10.3181/00379727-188-42746. [DOI] [PubMed] [Google Scholar]
  31. Lopez A. F., Nicola N. A., Burgess A. W., Metcalf D., Battye F. L., Sewell W. A., Vadas M. Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol. 1983 Dec;131(6):2983–2988. [PubMed] [Google Scholar]
  32. Matteucci D., Giangregorio A. M., Lopez-Cepero M., Specter S., Bendinelli M., Friedman H. Interleukins 1 and 2 production and responsiveness in the early stages of retroviral infections of mice. Cell Immunol. 1989 Apr 15;120(1):10–20. doi: 10.1016/0008-8749(89)90170-6. [DOI] [PubMed] [Google Scholar]
  33. Moody D. J., Specter S., Bendinelli M., Friedman H. Suppression of natural killer cell activity by Friend murine leukemia virus. J Natl Cancer Inst. 1984 Jun;72(6):1349–1356. [PubMed] [Google Scholar]
  34. Morrison C. J., Brummer E., Stevens D. A. In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing. Infect Immun. 1989 Oct;57(10):2953–2958. doi: 10.1128/iai.57.10.2953-2958.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Morrison R. P., Nishio J., Chesebro B. Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression. J Exp Med. 1986 Feb 1;163(2):301–314. doi: 10.1084/jem.163.2.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mortensen R. F., Ceglowski W. S., Friedman H. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus. J Immunol. 1973 Dec;111(6):1810–1819. [PubMed] [Google Scholar]
  37. Mortensen R. F., Ceglowski W. S., Friedman H. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus. J Immunol. 1974 Jun;112(6):2077–2086. [PubMed] [Google Scholar]
  38. Odaka T., Ishi H., Yamaura K., Yamamoto T. Inhibitory effect of Friend leukemia virus infection on the antibody formation to sheep erythrocytes in mice. Jpn J Exp Med. 1966 Jun;36(3):277–290. [PubMed] [Google Scholar]
  39. Rogers T. J., Balish E., Manning D. D. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc. 1976 Oct;20(4):291–298. [PubMed] [Google Scholar]
  40. Rogers T. J., Balish E. The role of activated macrophages in resistance to experimental renal candidiasis. J Reticuloendothel Soc. 1977 Oct;22(4):309–318. [PubMed] [Google Scholar]
  41. Rogers T., Balish E. Experimental Candida albicans infection in conventional mice and germfree rats. Infect Immun. 1976 Jul;14(1):33–38. doi: 10.1128/iai.14.1.33-38.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  43. Weisbart R. H., Golde D. W., Clark S. C., Wong G. G., Gasson J. C. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. 1985 Mar 28-Apr 3Nature. 314(6009):361–363. doi: 10.1038/314361a0. [DOI] [PubMed] [Google Scholar]
  44. Wu-Hsieh B., Howard D. H., Ahmed R. Virus-induced immunosuppression: a murine model of susceptibility to opportunistic infection. J Infect Dis. 1988 Jul;158(1):232–235. doi: 10.1093/infdis/158.1.232. [DOI] [PubMed] [Google Scholar]
  45. Yoo T. J., Bennett M. Effect of herpes simplex virus type 2 and friend erythroleukemia virus infection of IgE antibody responses to Ascaris antigen in mice. Int Arch Allergy Appl Immunol. 1981;65(2):235–238. doi: 10.1159/000232760. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES